News & Updates
Filter by Specialty:
Dupilumab, ruxolitinib deliver benefits to atopic dermatitis patients
Treatment with dupilumab increases the levels of bone alkaline phosphatase (BALP), a marker of bone mineralization, in paediatric patients with moderate-to-severe atopic dermatitis (AD), regardless of asthma comorbidity, reports a study presented at ACAAI 2023.
Dupilumab, ruxolitinib deliver benefits to atopic dermatitis patients
17 Nov 2023Biologic therapy improves life quality of asthmatic children
Treatment with biologic agents results in significant improvements in both function and quality of life among paediatric patients with moderate-to-severe asthma, according to a recent study presented at ACAAI 2023.
Biologic therapy improves life quality of asthmatic children
17 Nov 2023RNAi agent RG6346 shows promise for treatment of chronic HBV infection
A first-in-human randomized, phase I study has provided evidence to support the clinical development of RG6346 as a therapeutic regimen for chronic hepatitis B virus (HBV) infection (CHB), with the goal of sustained hepatitis B surface antigen (HBsAg) loss in CHB patients.
RNAi agent RG6346 shows promise for treatment of chronic HBV infection
17 Nov 2023Physical activity aids in recovery of cardiopulmonary function after lung cancer surgery
Cardiopulmonary function (CPF) recovery failure at 6 months after lung cancer surgery appears to be driven by reductions in lung function and moderate-to-vigorous physical activity (MVPA) from baseline to 2 weeks, suggests a study. Baseline PA and dyspnoea are also associated with the inability to recover CPF.
Physical activity aids in recovery of cardiopulmonary function after lung cancer surgery
16 Nov 2023Older adults in SG display high levels of knowledge, attitude of COVID-19
Most older adults living in Singapore have good knowledge of the common symptoms of COVID-19 and awareness of government-endorsed preventive measures, according to a recent study.